Related Experiment Video
Updated: Aug 22, 2025

Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy
Published on: October 4, 2019
Identification of potential microRNAs regulating metabolic plasticity and cellular phenotypes in glioblastoma
Rupa Bhowmick1,2, Ram Rup Sarkar3,4
1Chemical Engineering and Process Development Division, CSIR-National Chemical Laboratory, Pune, Maharashtra, 411008, India.
Abstract:
MicroRNAs (miRNAs) play important role in regulating cellular metabolism, and are currently being explored in cancer. As metabolic reprogramming in cancer is a major mediator of phenotypic plasticity, understanding miRNA-regulated metabolism will provide opportunities to identify miRNA targets that can regulate oncogenic phenotypes by taking control of cellular metabolism. In the present work, we studied the effect of differentially expressed miRNAs on metabolism, and associated oncogenic phenotypes in glioblastoma (GBM) using patient-derived data. Networks of differentially expressed miRNAs and metabolic genes were created and analyzed to identify important miRNAs that regulate major metabolism in GBM. Graph network-based approaches like network diffusion, backbone extraction, and different centrality measures were used to analyze these networks for identification of potential miRNA targets. Important metabolic processes and cellular phenotypes were annotated to trace the functional responses associated with these miRNA-regulated metabolic genes and associated phenotype networks. miRNA-regulated metabolic gene subnetworks of cellular phenotypes were extracted, and important miRNAs regulating these phenotypes were identified. The most important outcome of the study is the target miRNA combinations predicted for five different oncogenic phenotypes that can be tested experimentally for miRNA-based therapeutic design in GBM. Strategies implemented in the study can be used to generate testable hypotheses in other cancer types as well, and design context-specific miRNA-based therapy for individual patient. Their usability can be further extended to other gene regulatory networks in cancer and other genetic diseases.
Insights
This study identifies key microRNAs (miRNAs) that regulate metabolism and oncogenic phenotypes in glioblastoma. Findings offer potential miRNA combinations for targeted glioblastoma therapy development.
Area of Science:
- Oncology
- Genetics
- Systems Biology
Background:
- MicroRNAs (miRNAs) are crucial regulators of cellular metabolism.
- Metabolic reprogramming significantly drives cancer's phenotypic plasticity.
- Understanding miRNA-metabolism interactions is key for cancer therapy development.
Purpose of the Study:
- To investigate the impact of differentially expressed miRNAs on metabolism and oncogenic phenotypes in glioblastoma (GBM).
- To identify specific miRNA targets for regulating GBM's cellular metabolism and oncogenic traits.
Main Methods:
- Analysis of patient-derived glioblastoma data.
- Construction and analysis of miRNA-metabolic gene networks using graph network approaches (network diffusion, backbone extraction, centrality measures).
- Annotation of metabolic processes and cellular phenotypes to identify functional responses.
Main Results:
- Identification of key miRNAs regulating major metabolic pathways in GBM.
- Extraction of miRNA-regulated metabolic gene subnetworks linked to specific cellular phenotypes.
- Prediction of target miRNA combinations for five distinct oncogenic phenotypes in GBM.
Conclusions:
- The study provides potential miRNA combinations for experimental validation in glioblastoma therapy.
- The implemented strategies can generate hypotheses for other cancer types and personalized miRNA-based therapies.
- The approach is extendable to other gene regulatory networks in cancer and genetic diseases.

